Effectiveness of mass dengue vaccination with CYD-TDV (Dengvaxia®) in the state of Paraná, Brazil: integrating case-cohort and case-control designsResearch in context

• Main Authors: Fredi Alexander Diaz-Quijano (Author), Denise Siqueira de Carvalho (Author), Sonia Mara Raboni (Author), Silvia Emiko Shimakura (Author), Angela Maron de Mello (Author), Magda Clara Vieira da Costa-Ribeiro (Author), Lineu Silva (Author), Marilene da Cruz Magalhães Buffon (Author), Eliane Mara Cesario Pereira Maluf (Author), Gabriel Graeff (Author), Gustavo Almeida (Author), Clara Preto (Author), Karin Regina Luhm (Author)
• Format: Book
• Published: Elsevier, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: CYD-TDV (Dengvaxia®) was the first dengue vaccine approved, launched in Brazil in 2015 for individuals aged 9-44 years. We aimed to estimate the effectiveness of CYD-TDV in preventing symptomatic dengue cases during a campaign targeting individuals aged 15-27 years in selected m...